These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New antibiotic therapies for acne and rosacea. Mays RM; Gordon RA; Wilson JM; Silapunt S Dermatol Ther; 2012; 25(1):23-37. PubMed ID: 22591497 [TBL] [Abstract][Full Text] [Related]
6. The role of nicotinamide in acne treatment. Walocko FM; Eber AE; Keri JE; Al-Harbi MA; Nouri K Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28220628 [TBL] [Abstract][Full Text] [Related]
7. A review of nicotinamide: treatment of skin diseases and potential side effects. Rolfe HM J Cosmet Dermatol; 2014 Dec; 13(4):324-8. PubMed ID: 25399625 [TBL] [Abstract][Full Text] [Related]
8. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea. McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397 [TBL] [Abstract][Full Text] [Related]
9. Recently approved systemic therapies for acne vulgaris and rosacea. Del Rosso JQ Cutis; 2007 Aug; 80(2):113-20. PubMed ID: 17944168 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Del Rosso JQ; Leyden JJ; Thiboutot D; Webster GF Cutis; 2008 Aug; 82(2 Suppl 2):5-12. PubMed ID: 18924545 [TBL] [Abstract][Full Text] [Related]
11. Tetracyclines: nonantibiotic properties and their clinical implications. Sapadin AN; Fleischmajer R J Am Acad Dermatol; 2006 Feb; 54(2):258-65. PubMed ID: 16443056 [TBL] [Abstract][Full Text] [Related]
12. Inflammation in rosacea and acne: Implications for patient care. Fleischer AB J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194 [TBL] [Abstract][Full Text] [Related]
13. [The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea]. Kaszuba-Bartkowiak K; Goś R Przegl Lek; 2007; 64(12):991-6. PubMed ID: 18595500 [TBL] [Abstract][Full Text] [Related]
15. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Leyden JJ; Del Rosso JQ; Webster GF Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854 [TBL] [Abstract][Full Text] [Related]
16. [Oxytetracycline--mechanism of action and application in skin diseases]. Olszewska M Wiad Lek; 2006; 59(11-12):829-33. PubMed ID: 17427500 [TBL] [Abstract][Full Text] [Related]
17. [Roaccutan in acne and rosacea]. Mahrle G; Bauermeister-Jasso K; Enderer K Z Hautkr; 1985 Jan; 60(1-2):120, 125-34. PubMed ID: 3157273 [TBL] [Abstract][Full Text] [Related]
18. Acne and rosacea: What's new for treatment? Dursun R; Daye M; Durmaz K Dermatol Ther; 2019 Sep; 32(5):e13020. PubMed ID: 31294907 [TBL] [Abstract][Full Text] [Related]
19. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Pickert A; Raimer S Expert Opin Pharmacother; 2009 Jun; 10(9):1515-21. PubMed ID: 19505219 [TBL] [Abstract][Full Text] [Related]
20. [Tetracyclines as anti-inflammatory treatment in skin diseases]. Autio P; Keski-Oja J Nord Med; 1996 Dec; 111(10):348-51. PubMed ID: 8992467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]